Dopamine D2 receptor agonists inhibit lung cancer progression by reducing angiogenesis and tumor infiltrating myeloid derived suppressor cells
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dopamine D2 receptor agonists inhibit lung cancer progression by reducing angiogenesis and tumor infiltrating myeloid derived suppressor cells
Authors
Keywords
-
Journal
Molecular Oncology
Volume 9, Issue 1, Pages 270-281
Publisher
Wiley
Online
2014-08-31
DOI
10.1016/j.molonc.2014.08.008
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The 2014 Surgeon General's Report: Commemorating the 50th Anniversary of the 1964 Report of the Advisory Committee to the US Surgeon General and Updating the Evidence on the Health Consequences of Cigarette Smoking
- (2014) A. J. Alberg et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Multitargeted anti-angiogenic agents and NSCLC: Clinical update and future directions
- (2012) Peter M. Ellis et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Effect of cigarette smoking on quality of life in small cell lung cancer patients
- (2012) Jun Chen et al. EUROPEAN JOURNAL OF CANCER
- Paraoxonase 2 decreases renal reactive oxygen species production, lowers blood pressure, and mediates dopamine D2 receptor-induced inhibition of NADPH oxidase
- (2012) Yu Yang et al. FREE RADICAL BIOLOGY AND MEDICINE
- Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study
- (2012) Thomas J. Lynch et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Survival by histologic subtype in stage IV nonsmall cell lung cancer based on data from the Surveillance, Epidemiology and End Results Program
- (2011) Karynsa Cetin et al. Clinical Epidemiology
- Vascular Endothelial Growth Factor Receptors VEGFR-2 and VEGFR-3 Are Localized Primarily to the Vasculature in Human Primary Solid Cancers
- (2010) N. R. Smith et al. CLINICAL CANCER RESEARCH
- Nicotinic acetylcholine receptors and predisposition to lung cancer
- (2010) Jean-Marie Tournier et al. CURRENT OPINION IN ONCOLOGY
- Antiangiogenic therapy in lung cancer: focus on vascular endothelial growth factor pathway
- (2010) Grzegorz Korpanty et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Dual Targeting of the Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor Pathways with Vandetinib (ZD6474) in Patients with Advanced or Metastatic Non-small Cell Lung Cancer
- (2010) Ronald B. Natale Journal of Thoracic Oncology
- Multiple Independent Loci at Chromosome 15q25.1 Affect Smoking Quantity: a Meta-Analysis and Comparison with Lung Cancer and COPD
- (2010) Nancy L. Saccone et al. PLoS Genetics
- The 15q24/25 Susceptibility Variant for Lung Cancer and Chronic Obstructive Pulmonary Disease Is Associated with Emphysema
- (2009) Diether Lambrechts et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Dopamine regulates phosphorylation of VEGF receptor 2 by engaging Src-homology-2-domain-containing protein tyrosine phosphatase 2
- (2009) S. Sinha et al. JOURNAL OF CELL SCIENCE
- Mechanism Regulating Reactive Oxygen Species in Tumor-Induced Myeloid-Derived Suppressor Cells
- (2009) C. A. Corzo et al. JOURNAL OF IMMUNOLOGY
- Prognostic factors for limited-stage small cell lung cancer: A study of 284 patients
- (2009) Jun Chen et al. LUNG CANCER
- The impact of genetic variation in DRD2 and SLC6A3 on smoking cessation in a cohort of participants 1 year after enrollment in a lung cancer screening study
- (2008) Mindi A. Styn et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Pharmacology of Nicotine: Addiction, Smoking-Induced Disease, and Therapeutics
- (2008) Neal L. Benowitz Annual Review of Pharmacology and Toxicology
- Dopamine Increases the Efficacy of Anticancer Drugs in Breast and Colon Cancer Preclinical Models
- (2008) C. Sarkar et al. CLINICAL CANCER RESEARCH
- Dopamine regulates endothelial progenitor cell mobilization from mouse bone marrow in tumor vascularization
- (2008) Debanjan Chakroborty et al. JOURNAL OF CLINICAL INVESTIGATION
- The CHRNA5-A3 Region on Chromosome 15q24-25.1 Is a Risk Factor Both for Nicotine Dependence and for Lung Cancer
- (2008) Margaret R. Spitz et al. JNCI-Journal of the National Cancer Institute
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now